Latest News for AHKSF
CHELMSFORD, Mass. & TOKYO--(BUSINESS WIRE)--Asahi Kasei announced it has entered into a definitive agreement to acquire all issued shares of Aicuris Anti-infective Cures AG.
TOKYO--(BUSINESS WIRE)--Asahi Kasei Pharma announced an exclusive global license agreement regarding novel lead compounds for a single target with Alchemedicine.
TOKYO--(BUSINESS WIRE)--Asahi Kasei Pharma in collaboration with Alchemedicine has announced that AK1960 has advanced to a Phase I clinical study.
DUESSELDORF, Germany--(BUSINESS WIRE)--Asahi Kasei announced the development of a new PFAS-free polyamide (PA) engineered specifically for demanding low-friction applications.
CHELMSFORD, Mass. & TOKYO--(BUSINESS WIRE)--Asahi Kasei announced that ZOLL® Medical has launched the next-generation LifeVest® wearable cardioverter defibrillator (WCD) in the U.S.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for AHKSF.
Senate Trading
No Senate trades found for AHKSF.
U.S. House Trading
No House trades found for AHKSF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.